![Piet Wigerinck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Piet Wigerinck
Directeur/Bestuurslid bij
IPSEN
Vermogen: 124 266 $ op 31-05-2026
Profiel
Momenteel is Piet Wigerinck Chief Scientific Officer van Galapagos NV. Hij is ook lid van de raad van bestuur van Ipsen SA en Ipsen Pharma SAS. In het verleden was hij Vice President-Drug Discovery & Early Development bij Tibotec Pharmaceuticals en Vice President van Drug Discovery & Development Solutions Ltd. Dr. Wigerinck behaalde een doctoraat aan de Katholieke Universiteit Leuven.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IPSEN SA 0% | 31-12-2025 | 680 ( 0% ) | 124 266 $ | 31-05-2026 |
Actieve functies van Piet Wigerinck
| Bedrijven | Functie | Begin |
|---|---|---|
| IPSEN | Directeur/Bestuurslid | 01-05-2018 |
Antwerp University Hospital
 Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Directeur/Bestuurslid | - |
miDIAGNOSTICS NV
 miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Directeur/Bestuurslid | - |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Directeur/Bestuurslid | - |
Symeres BV
 Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Directeur/Bestuurslid | - |
Eerdere bekende functies van Piet Wigerinck
| Bedrijven | Functie | Einde |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Hoofd Techniek/Wetenschap/O&O | 31-12-2021 |
UZA Foundation | Directeur/Bestuurslid | - |
Xinvento BV
 Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Oprichter | - |
Tibotec Virco Comm. VA
 Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Piet Wigerinck
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
62
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Antwerp University Hospital
Antwerp University Hospital Hospital/Nursing ManagementHealth Services Provides clinical, patient care, academic training and scientific research services | Health Services |
Tibotec Virco Comm. VA
Tibotec Virco Comm. VA Pharmaceuticals: MajorHealth Technology Provides medicine | Health Technology |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services Develops a computer chip powered portable medical laboratory | Commercial Services |
Drug Discovery & Development Solutions Ltd.
 Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in drug discovery and development | Commercial Services |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
Symeres BV
Symeres BV BiotechnologyHealth Technology Operates as a contract research organization for drug discovery and development activities | Health Technology |
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Operates as a biotech company that develops therapies for congenital hyperinsulinism | Health Technology |
UZA Foundation |
